Literature DB >> 25213336

Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch.

Xinxin Xiang1, He Lan2, Hong Tang2, Fang Yuan2, Yanhui Xu2, Jing Zhao2, Yin Li3, Weizhen Zhang4.   

Abstract

Interconversion of white and brown adipocytes occurs between anabolic and catabolic states. The molecular mechanism regulating this phenotypic switch remains largely unknown. This study explores the role of tuberous sclerosis complex 1 (TSC1)-mechanistic target of rapamycin (mTOR) signaling in the conversion of brown to white adipose tissue (WAT). A colony of Fabp4-Tsc1(-/-) mice, in which the Tsc1 gene was specifically deleted by the fatty acid binding protein 4 (FABP4)-Cre, was established. Western blotting and immunostaining demonstrated the absence of TSC1 and activation of ribosomal protein S6 kinase 1, the downstream target of mTOR complex 1 (mTORC1) signaling, in the brown adipose tissues (BATs) of Fabp4-Tsc1(-/-) mice. Accumulation of lipid droplets in BAT was significantly increased. Levels of brown adipocyte markers were markedly downregulated, while white adipocyte markers were upregulated. Rapamycin reversed the conversion from BAT to WAT in Fabp4-Tsc1(-/-) mice. Deletion of the Tsc1 gene in cultured brown preadipocytes significantly increased the conversion to white adipocytes. FoxC2 mRNA, the transcriptional factor for brown adipocyte determination, was significantly decreased, while mRNAs for retinoblastoma protein, p107 and RIP140, the transcriptional factors for white adipocyte determination, increased in the BAT of Fabp4-Tsc1(-/-) mice. Our study demonstrates that TSC1-mTORC1 signaling contributes to the brown-to-white adipocyte phenotypic switch.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213336     DOI: 10.2337/db14-0427

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  Hypothalamic roles of mTOR complex I: integration of nutrient and hormone signals to regulate energy homeostasis.

Authors:  Fang Hu; Yong Xu; Feng Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

Review 2.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening.

Authors:  Jiali Deng; Yajie Guo; Feixiang Yuan; Shanghai Chen; Hanrui Yin; Xiaoxue Jiang; Fuxin Jiao; Fenfen Wang; Hongbin Ji; Guohong Hu; Hao Ying; Yan Chen; Qiwei Zhai; Fei Xiao; Feifan Guo
Journal:  Autophagy       Date:  2019-06-18       Impact factor: 16.016

4.  Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue.

Authors:  Cassie M Tran; Sarmistha Mukherjee; Lan Ye; David W Frederick; Megan Kissig; James G Davis; Dudley W Lamming; Patrick Seale; Joseph A Baur
Journal:  Diabetes       Date:  2016-02-08       Impact factor: 9.461

Review 5.  Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions.

Authors:  Abdikarim Abdullahi; Marc G Jeschke
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

6.  Adrenomedullin 2 Enhances Beiging in White Adipose Tissue Directly in an Adipocyte-autonomous Manner and Indirectly through Activation of M2 Macrophages.

Authors:  Ying Lv; Song-Yang Zhang; Xianyi Liang; Heng Zhang; Zhi Xu; Bo Liu; Ming-Jiang Xu; Changtao Jiang; Jin Shang; Xian Wang
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

7.  Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice.

Authors:  Tizhong Shan; Pengpeng Zhang; Qinyang Jiang; Yan Xiong; Yizhen Wang; Shihuan Kuang
Journal:  Diabetologia       Date:  2016-06-13       Impact factor: 10.122

Review 8.  Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects.

Authors:  Huan Cai; Lily Q Dong; Feng Liu
Journal:  Trends Pharmacol Sci       Date:  2015-12-14       Impact factor: 14.819

9.  Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance.

Authors:  Yan Xiong; Ziye Xu; Yizhen Wang; Shihuan Kuang; Tizhong Shan
Journal:  J Lipid Res       Date:  2018-04-10       Impact factor: 5.922

Review 10.  Role of TSC1 in physiology and diseases.

Authors:  Karthik Mallela; Arun Kumar
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.